M
RANI icon

MOTCO’s Rani Therapeutics RANI Stock Holding History

MOTCO’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.6K Hold
48,129
– – ﹤0.01% 339
2026
Q1 		$35.4K Hold
48,129
– – ﹤0.01% 359
2025
Q4 		$65K Hold
48,129
– – 0.01% 304
2025
Q3 		$24.1K Hold
48,129
– – ﹤0.01% 394
2025
Q2 		$25.8K Hold
48,129
– – ﹤0.01% 364
2025
Q1 		$60.6K Hold
48,129
– – 0.01% 278
2024
Q4 		$65.9K Hold
48,129
– – 0.01% 263
2024
Q3 		$104K Hold
48,129
– – 0.01% 254
2024
Q2 		$183K Hold
48,129
– – 0.01% 283
2024
Q1 		$150K Hold
48,129
– – 0.01% 298
2023
Q4 		$160K Hold
48,129
– – 0.01% 265
2023
Q3 		$105K Hold
48,129
– – 0.01% 286
2023
Q2 		$198K Hold
48,129
– – 0.01% 233
2023
Q1 		$248K Hold
48,129
– – 0.02% 211
2022
Q4 		$284K Hold
48,129
– – 0.02% 197
2022
Q3 		$461K Buy
+48,129
New +$510K 0.04% 174

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

MOTCO's RANI Position: Q2 2026 in Review

MOTCO held its Rani Therapeutics (RANI) position steady in Q2 2026 at 48,129 shares worth $36.6K. The position accounts for ﹤0.01% of the portfolio, ranked #339.

MOTCO first reported a position in RANI in Q3 2022 and has held it in 16 quarters since. The position peaked at $461K in Q3 2022. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • MOTCO held 48,129 shares of Rani Therapeutics worth $36.6K as of Q2 2026.
  • MOTCO left its Rani Therapeutics share count unchanged in Q2 2026.
  • Rani Therapeutics made up ﹤0.01% of MOTCO's portfolio in Q2 2026, its #339 holding.
  • MOTCO first reported a position in Rani Therapeutics in Q3 2022 and has held it in 16 quarters since.
  • MOTCO's Rani Therapeutics position peaked at $461K in Q3 2022.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on MOTCO's 13F filing for Q2 2026, filed 31 Jul 2026.